Testing effectiveness (Phase 2)Looking for participantsNCT07081646
What this trial is testing
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Who this might be right for
Relapsed AL AmyloidosisRefractory AL AmyloidosisLight Chain Amyloidosis+1 more
Alexion Pharmaceuticals, Inc. 91